These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19423105)

  • 1. Effect of selective serotonin reuptake inhibitors on in vitro fertilization outcome.
    Friedman BE; Rogers JL; Shahine LK; Westphal LM; Lathi RB
    Fertil Steril; 2009 Oct; 92(4):1312-1314. PubMed ID: 19423105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryo aneuploidy is not impacted by selective serotonin reuptake inhibitor exposure.
    Hernandez-Nieto C; Lee J; Nazem T; Gounko D; Copperman A; Sandler B
    Fertil Steril; 2017 Dec; 108(6):973-979. PubMed ID: 29202974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction: the dual-action debate: does pharmacology matter?
    Thase ME
    J Clin Psychiatry; 2004; 65 Suppl 17():3-4. PubMed ID: 15600375
    [No Abstract]   [Full Text] [Related]  

  • 4. SSRIs in pregnancy--are they safe?
    Koren G
    Pediatr Res; 2002 Apr; 51(4):424-5. PubMed ID: 11919325
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of SSRIs during pregnancy: a controlled study.
    Altamura AC; De Gaspari IF; Rovera C; Colombo EM; Mauri MC; Fedele L
    Hum Psychopharmacol; 2013 Jan; 28(1):25-8. PubMed ID: 23166037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective serotonin reuptake inhibitors controversy in the treatment of depression in children.
    Weller EB; Tucker S; Weller RA
    Curr Psychiatry Rep; 2005 Apr; 7(2):87-90. PubMed ID: 15802083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reaction on 'Dose-escalation of SSRIS in major depressive disorder. Should not be recommended in current guidelines'].
    Moleman P
    Tijdschr Psychiatr; 2010; 52(11):801-2; author reply 802-4. PubMed ID: 21064023
    [No Abstract]   [Full Text] [Related]  

  • 9. The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyond.
    Domar AD; Moragianni VA; Ryley DA; Urato AC
    Hum Reprod; 2013 Jan; 28(1):160-71. PubMed ID: 23117129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serotonin neurotrasmission and treatment options for depression].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):174-177. PubMed ID: 29265105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple serotonergic paths to antidepressant efficacy.
    Lutz PE
    J Neurophysiol; 2013 May; 109(9):2245-9. PubMed ID: 23343901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials.
    Papakostas GI; Trivedi MH; Alpert JE; Seifert CA; Krishen A; Goodale EP; Tucker VL
    J Psychiatr Res; 2008 Jan; 42(2):134-40. PubMed ID: 17631898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine during pregnancy: impact on fetal development.
    Morrison JL; Riggs KW; Rurak DW
    Reprod Fertil Dev; 2005; 17(6):641-50. PubMed ID: 16263070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Serotonin Reuptake Inhibitors and Fertility: Considerations for Couples Trying to Conceive.
    Sylvester C; Menke M; Gopalan P
    Harv Rev Psychiatry; 2019; 27(2):108-118. PubMed ID: 30676405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies.
    de Silva VA; Hanwella R
    Int Clin Psychopharmacol; 2012 Jan; 27(1):8-16. PubMed ID: 21971532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin and the prediction of response time to fluoxetine in patients with mild depression.
    New AS; Woo-Ming A; Mitropoulou V; Silverman J; Reynolds D; Schopick F; Trestman RL; Siever LJ
    Psychiatry Res; 1999 Nov; 88(2):89-93. PubMed ID: 10622345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
    Entsuah AR; Huang H; Thase ME
    J Clin Psychiatry; 2001 Nov; 62(11):869-77. PubMed ID: 11775046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram (Lexapro) for depression.
    Masilamani S; Ruppelt SC
    Am Fam Physician; 2003 Dec; 68(11):2235-6. PubMed ID: 14677669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.
    Yonkers KA; Norwitz ER; Smith MV; Lockwood CJ; Gotman N; Luchansky E; Lin H; Belanger K
    Epidemiology; 2012 Sep; 23(5):677-85. PubMed ID: 22627901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of the relationship between selective serotonin reuptake inhibitors and in vitro fertilization outcome.
    Klock SC; Sheinin S; Kazer R; Zhang X
    Fertil Steril; 2004 Oct; 82(4):968-9. PubMed ID: 15482784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.